Literature DB >> 18453622

Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction.

Naozumi Ishimaru1, Akiko Yamada, Masayuki Kohashi, Rieko Arakaki, Tetsuyuki Takahashi, Keisuke Izumi, Yoshio Hayashi.   

Abstract

A mutant strain with defective thymic selection of the Long-Evans Cinnamon (LEC) rat was found to spontaneously develop inflammatory bowel disease (IBD)-like colitis. The secretion of Th1-type cytokines including IFN-gamma and IL-2 from T cells of mesenteric lymph node cells (MLNs) and lamina propria mononuclear cells, but not spleen cells, in LEC rats was significantly increased more than that of the control Long-Evans Agouti rats through up-regulated expression of T-bet and phosphorylation of STAT-1 leading to NF-kappaB activation. In addition, the number of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells of the thymus, MLNs, and lamina propria mononuclear cells from LEC rats was significantly reduced, comparing with that of the control rats. Moreover, bone marrow cell transfer from LEC rats into irradiated control rats revealed significantly reduced CD25(+)Foxp3(+) Treg cells in thymus, spleen, and MLNs compared with those from control rats. Indeed, adoptive transfer with T cells of MLNs, not spleen cells, from LEC rats into SCID mice resulted in the development of inflammatory lesions resembling the IBD-like lesions observed in LEC rats. These results indicate that the dysfunction of the regulatory system controlled by Treg cells may play a crucial role in the development of IBD-like lesions through up-regulated T-bet, STAT-1, and NF-kappaB activation of peripheral T cells in LEC rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453622     DOI: 10.4049/jimmunol.180.10.6997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Takaaki Tsunematsu; Yasusei Kudo; Naozumi Ishimaru
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Th17 and regulatory T cells: implications for AIDS pathogenesis.

Authors:  Bittoo Kanwar; David Favre; Joseph M McCune
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

3.  Long-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.

Authors:  Geraldo Gs Oliveira; John Holton; Peter M Lydyard
Journal:  Gut Microbes       Date:  2010-05-24

4.  Adoptive regulatory T-cell therapy protects against cerebral ischemia.

Authors:  Peiying Li; Yu Gan; Bao-Liang Sun; Feng Zhang; Binfeng Lu; Yanqin Gao; Weimin Liang; Angus W Thomson; Jun Chen; Xiaoming Hu
Journal:  Ann Neurol       Date:  2013-05-14       Impact factor: 10.422

5.  Mevalonate promotes differentiation of regulatory T cells.

Authors:  Suman Acharya; Maheshwor Timilshina; Jae-Hoon Chang
Journal:  J Mol Med (Berl)       Date:  2019-04-24       Impact factor: 4.599

6.  Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease.

Authors:  D Ishikawa; A Okazawa; D Corridoni; L G Jia; X M Wang; M Guanzon; W Xin; K O Arseneau; T T Pizarro; F Cominelli
Journal:  Mucosal Immunol       Date:  2012-07-11       Impact factor: 7.313

7.  Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs.

Authors:  Johannes Junginger; Ulrike Schwittlick; Frederik Lemensieck; Ingo Nolte; Marion Hewicker-Trautwein
Journal:  Vet Res       Date:  2012-03-22       Impact factor: 3.683

Review 8.  Thymic epithelial cell development and its dysfunction in human diseases.

Authors:  Lina Sun; Hongran Li; Haiying Luo; Yong Zhao
Journal:  Biomed Res Int       Date:  2014-02-03       Impact factor: 3.411

9.  In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Takeshi Nitta; Rieko Arakaki; Akiko Yamada; Martin Lipp; Yousuke Takahama; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

10.  A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.

Authors:  Li-Guo Jia; Giorgos Bamias; Kristen O Arseneau; Linda C Burkly; Eddy C Y Wang; Dennis Gruszka; Theresa T Pizarro; Fabio Cominelli
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.